Your Location:
Home >
Browse articles >
Shaoyaotang Treats Ulcerative Colitis by Inhibiting HIF-1α and Regulating Th17/Treg Balance
Shaoyaotang Treats Ulcerative Colitis by Inhibiting HIF-1
α and Regulating Th17/Treg Balance- Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 16, Pages: 9-15(2021)
DOI: 10.13422/j.cnki.syfjx.20211503
Scan QR Code
Full Text(HTML)
Figs( 4 ) Tabs( 5 )
References
Publication Info
Metrics
178
Views
111
Downloads
22
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Effect of Schisanlactone E on Neuroinflammation and Synaptic Damage in APP/PS1 Mice and Their Relationship with Th17/Treg Immune Balance
Mechanism of Shaoyaotang in Ameliorating Colitis-associated Carcinogenesis in Mice via Modulating AMPK/NF-κB/HIF-1α Signaling Pathway
Shaoyaotang Regulates TLR4/MyD88/NF-κB Signaling Pathway to Protect Intestinal Mucosal Barrier in Ulcerative Colitis
Shaoyaotang Regulates miRNA-155-mediated SOCS1/JAK1/STAT1 Signaling Pathway to Affect Macrophage Polarization
Shaoyaotang Ameliorates Ulcerative Colitis by Regulating miR-155-5p
Related Author
YU Wenjing
YANG Miao
HE Chunxiang
HE Jiawei
SONG Zhenyan
LI Ping
CHENG Shaowu
CHEN Xue
Related Institution
School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine
Hunan Province Key Laboratory of Cerebrovascular Disease Prevention and Treatment of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine
Medical School, Hunan University of Chinese Medicine
Shaanxi University of Chinese Medicine
Hospital of Chengdu University of Traditional Chinese Medicine


